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Summary Studies were performed to determine whether localized treatment of subcutaneously growing
Lewis Lung Carcinoma (LLC) in C57BL/6 mice with porphyrin photodynamic therapy (PDT) affects the
formation of distant metastases. Treatments consisted of a 10mgkg-' dose of dihematoporphyrin-ether
(Photofrin 11) followed 24h later by local tumour irradiation with 630nm red light. Total doses of light
ranged from 0-500Jcm-2 and the irradiance of delivered light was 150mWcm-2. Primary LLC tumours
were treated at a volume of 25-30mm3, and lung metastases were determined 21 days following
transplantation. Mice exposed to PDT treatment which produced either partial or complete local tumoricidal
responses had significantly decreased numbers of metastatic lung colonies compared to controls. In addition,
PDT treated mice had equal or less metastatic lung colonies than comparable mice treated with local surgical
excision of the primary LLC lesion. These results indicate that local PDT does not enhance metastatic spread
of LLC following either curative or noncurative treatments.
Photodynamic therapy (PDT) continues to show promise in early stage malignancies combined with the continued
the clinical treatment of solid tumours (Dougherty et al., observations concerning induced vascular injury following
1982; Doiron & Gomer, 1984; Dougherty, 1984). Preferential PDT have led us to examine the relationship between PDT
uptake and retention of haematoporphyrin derivative or its and induction of tumour metastasis. The objective of our
active component di-haematoporphyrin ether (photofrin II) study was therefore to determine whether localized PDT
in malignant tissue compared to surrounding normal tissue treatments in C57BL/6 mice with subcutaneous Lewis lung
(Gomer & Dougherty, 1979; Little et al., 1984), together carcinoma affected tumour dissemination.
with the efficient photochemical production of cytotoxic
singlet oxygen by these compounds (Weishaupt et al., 1976)
account for the efficacy of PDT. The advancement in Materials and methods
clinically available lasers and fiberoptic light delivery systems
has also enhanced the selectivity with which tumour localized Drugs
porphyrins can be activated (Doiron et al., 1984; Moore, Photofrin II (dihematoporphyrin-ether) was obtained from 1984). Efficacy of PDT is currently being examined for the Photofrin Medical Co., Inc., Raritan, New Jersey, as a sterile treatment of obstructive or partially obstructive endo- soltion at a Con r of25m ml -1 Te as
bronchial tumours as well as for the treatment of transitional soluteon at a concentration of 2.5mgmo-a i The drug was
cell carcinoma and carcinoma in-situ of the bladder (Cortese diluted with sterile saline to obtain a workin concentration
& Kinsey, 1984; Hayata et al., 1984; Nseyo et al., 1985; of I mgml prior to i.p injection in mice receiving a dose >= rs . s . 9 s s ^ . ^of 10 mgkg-'. Photofrill I was not diluted prior to Benson, 1985). Preliminary clinical PDT results also remain o 1
encouraging for treating colorectal, ocular, brain, administration in animals receiving a 50 mg kg- dose.
gynaecologic, oesophageal, head and neck, and cutaneous
neoplasms (Herrera-Ornelas et al., 1986; Bruce, 1984; Cheng Animal and tumour model
et al., 1986; McCaughan et al., 1985; Wile et al., 1984; Tse et Female C57BL/6 mice were obtained from Jackson
al., 1984). Laboratories, Bar Harbor, Maine and were entered into
The expanding use of PDT in the clinic dictates that studies at 7 to 9 weeks of age. The Lewis lung carcinoma
studies be performed which will examine potential limitations (LLC) was obtained from the Division of Cancer Treatment
and/or side effects of this procedure. At the cellular level it Tumor Repository, NCI-Frederick Cancer Research Facility has been well documented that PDT can induce damage to and was grown as a subcutaneous mass for serial passage
the plasma membrane, cytoplasmic organelles and to nuclear and tumour cell transplantation. Single cell suspensions of
structures (Moan, 1986). While PDT can cause various types LLC were obtained by passing minced tumour pieces of nuclear damage, studies indicate that PDT does not through 19, 22 and 25 gauge needles. Viability of tumour induce mutagenic (Gomer et al., 1983) or carcinogenic cells (as determined by trypan blue exclusion) was always
changes in mammalian cells (Gomer, unpublished results). >95% and cells were counted on an electronic Coulter
Limitations or side-effects of clinical PDT are primarily counter. A total of 106 LLC cells in a volume of 0.05ml
related to the attenuation of visible red light in tumour tissue were injected s.c. in the right hind flank of experimental
(which limits the effective tumoricidal depth of PDT) and mice. Tumour volume was subsequently measured 3 times
transient skin photosensitivity following porphyrin adminis- per week using a vernier caliper. Tumours measuring
tration (Wan et al., 1981; Dougherty, 1984). However, an between 25-30mm3 were used in PDT and surgery
increasing number of studies continue to demonstrate that experiments.
direct vascular damage is induced by PDT (Selman et al.,
1984; Henderson et al., 1985; Star et al., 1986; Berenbaum et Tumour treatment protocols
al., 1986). The fact that PDT iS being suggested for use in
___________________________________________ A standard PDT treatment consisted of an i.p. injection of
Correspondence: C.J. Gomer, Clayton Center for Ocular Oncology, Photofrin II followed 24h later by localized exposure of the Childrens Hospital of Los Angeles, 4650 Sunset Boulevard, Los primary tumour to 630nm red light. A 1 cm diameter spot Angeles, California, USA 90027. size was utilized in all procedures and this allowed for both Received 5 January 1987; and in revised form, 9 March 1987. the tumour and a 1 to 2 mm margin of normal skin to be28 C.J. GOMER et al.
exposed to the light. Red light was generated from an argon implantation, had no effect on the growth rate of the
pumped dye laser (Spectra Physics, Mountain View, CA). A tumour (data not shown). Mice with tumours measuring
400gm diameter quartz fiberoptic cable was interfaced to the between 25-30mm3 (4-6 days following transplantation)
output of a dye laser and a microlens was attached to the were utilized in PDT treatments.
distal tip of the fiber for light delivery. The wavelength of Figure 2 shows the number of metastatic lung colonies
delivered light (630nm) was measured with a spectroscope observed in mice with subcutaneously growing LLC as a
(Cooper Lasersonics, Santa Clara, CA) and the light power function of time following transplantation. Metastatic lung
was determined using a power meter (Coherent Radiation, colonies were first observed 10 days following tumour
Palo Alto, CA). The irradiance or dose rate of delivered light transplantation. Between 50-70 metastatic colonies per lung
was kept at 150 mWcm-2 and the total light dose ranged were observed by day 21. The administration of Photofrin II
from 0-500 Jcm-2. All animals were restrained with tape five days following transplantation had no effect on the
during PDT treatment. number of metastatic lung colonies which were subsequently
Surgical excision of the primary LLC was performed in observed in the transplanted mice. All studies related to
certain experiments. In these procedures, animals were first quantification of metastatic lung colonies were performed 21
anaesthetized using an i.p. injection of sodium pentobarbital days following the s.c. transplantation of the 106 LLC cells.
(50mgkg-1). The primary lesion was then surgically excised
and the overlying skin sutured. The resection margin was
4mm and tumour recurrences were observed in the 80
subcutaneous space.
Quantification oflung metastasis ° 60-:1Control
Treated animals were sacrificed at various time intervals 0 * Photofrin II
following tumour transplantation. The lungs of these animals
were stained by injecting 2ml of India ink through the , 40
trachea, followed by washing and incubating for 24 h in
Feketes bleaching solution (Oda et al., 1986). Metastatic
lung colonies were then counted under a dissecting 20
microscope.
Tumour temperature measurements
0 t
A group of tumour bearing C57BL/6 mice were utilized to 8 10 12 14 16 18 20 22
document temperature measurements during PDT Days following tumour transplantation
treatments. A 21 gauge thermocouple hypodermic needle Days fowntu rtati on
(Omega Engineering, Inc., Stamford, CT) was inserted into Figure 2 Number ofmetastatie LLC lung colonies in C57BL/6 , ., . ~~~~~~~~~mice as a function of time following local tumour trans- the base of the LLC of mice treated with PDT. plantation. The control group (r-1) received no treatment while Temperatures were monitored as a function of light exposure the PhotofrinII group (-) received a single i.p. injection of
time. PhotofrinII (10mgkg-') 5 days following the initial tumour
transplantation. Each point represents the average of 10 mice.
Statistical analysis
The 2-tailed Student's t test was used for the evaluation of The standard PDT treatment, which utilized a light dose
all data.ThstnadPTtetet hc tlzdalg oe rate of 150 mWcm-2 induced a 6°C temperature rise at a
tumour depth of 2.5mm. The baseline temperature of the
Results tumours prior to PDT treatment averaged 33°C.
Table I shows the effect of PDT or surgery on the
Figure 1 shows the growth curve for LLC following sub- incidence of metastatic lung colonies in tumour bearing mice
cutaneous transplantation of 106 cells to the flank of when treatments were started when the primary flank lesion
C57BL/6 mice. Following a short lag period, the tumour measured 25-30mm3. In this group of experiments the
volume had a doubling time of -5 days. PhotofrinII, when primary subcutaneous tumours were treated 4 to 6 days
administered to tumour bearing mice 5 days following following transplantation. Control groups included animals
which received no treatment, photofrinII alone (either 10 or
50mgkg-1), or light treatment alone (400Jcm-2). A
300 Lewislungcarcinocomplete tumour response corresponds to those animals
treated with either PDT or surgery in which the primary
tumour did not reoccur prior to the time of sacrifice on day
21. A partial tumour response corresponds to those animals
E 200 in which the local tumour was observed to regrow prior to
a, sacrifice on day 21. There was no statistically significant
E difference in the number of metastatic lung colonies in any
o / of the control groups. In addition, the number of metastatic
. lung colonies in all groups of treated mice which had partial
O 100 - - ~~~~~~~~~~responseswere also statistically identical and averaged ~30.
= / ~~~~~~~~~~~~The number of metastatic lung colonies in the complete F - / ~~~~~~~~~~~~response groups of mice were significantly less following
,=/ ~~~~~~~~~~~PDT treatment (at all PDT doses) than for surgically treated
E , ~~~~~~~~mice. 0 10 20 30 Table II is a subpopulation of Table I and shows the
Days following transplantation effect of PDT or surgery on the incidence of metastatic lung
Figure 1 Growth rate of LLC tumour following transplantation colonies in tumour bearing mice when all treatments were
of 106 LLC cells to the hind flank of C57BL/6 mice. Tumour started 5 days following tumour implantation. In this set of
volumes were calculated using the formula axbxcx /6 and experiments, all mice treated with 100 or 200Jcm-2 of PDT
points represent the means of 12 individual tumours. had only partial responses. The number of metastatic lungLOCALIZED PORPHYRIN PHOTODYNAMIC THERAPY 29
Table I Effect of photodynamic therapy or surgery on the incidence of lung metastasis
in C57BL/6 mice with Lewis lung carcinomaa b.
Average number oflung colonies
Number of No Partial Complete
Treatment mice responsec responsed response' P values'
Control 83 67.9+8.59
Photofrin 11(10mgkg-) 33 64.0+6.3
Photofrin 11(50mgkg-') 13 56.3 +3.6
Light alone
150 mWCm-2
400Jcm-2 15 58.5+9.4
Surgery 14 30.1+10.7
Surgery 70 19.9+ 3.1
PDT, lOOJCm-2 14 36.0+ 8.0
PDT, 200Jcm-2 13 36.0+ 6.5
PDT, 200Jcm-2 2 0.5+0.4 <0.01
PDT, 300Jcm-2 28 16.0+ 4.0
PDT, 300Jcm-2 19 9.2+3.3 <0.05
PDT, 400Jcm-2 13 24.6+ 5.3
PDT, 400Jcm-2 5 0.8+0.5 <0.01
PDT, 500Jcm-2 8 25.6+10.1
PDT, 500Jcm-2 6 5.3+3.2 <0.01
aLungs examined 21 days following tumour transplantation; bPrimary tumours were
treated when the lesion measured 25-30mm3; cNo response - tumour did not respond to
treatment; dPartial response - local tumour regrowth prior to sacrifice; eComplete
response - no local tumour present at time of sacrifice; 'Two tailed Student t test:
*Surgery (complete response) vs PDT (complete response); gMean +s.e.
Table II Effect of photodynamic therapy or surgery on the incidence of lung metastasis
in C57BL/6 mice with Lewis lung carcinoma when treatments were delivered 5 days
following transplantationa b
Average number oflung colonies
Number of No Partial Complete
Treatment mice responsec responsed responsee P values'
Control 83 67.9+8.59
Photofrin II (10mgkg-l) 33 64.0+6.3
Photofrin 11(50mgkg-') 13 56.3 +3.6
Light alone
150 mW cm2
400Jcm2 15 58.5+9.4
Surgery 22 18.5 +6.6
Surgery 10 13.9+ 6.6
PDT, lOOJCm-2 9 37.4+12.5
PDT, 200Jcm-2 7 34.1+11.4
PDT, 300Jcm-2 18 15.4+ 5.7
PDT, 300JCm-2 16 6.6+3.0 >0.1
PDT, 400Jcm-2 8 22.8+ 8.6
PDT, 400Jcm-2 2 0.5+0.5 <0.05
PDT, 500J cm-2 7 29.2+ 10.8
PDT, 500Jcm-2 5 6.4+3.7 >0.1
aLungs examined 21 days following tumour transplantation; bPrimary tumours were
treated 5 days following tumour transplantation; 'No response - tumour did not respond
to treatment; dPartial response - local tumour regrowth prior to sacrifice; eComplete
response - no local tumour present at the time of sacrifice; 'Two tailed Student t test:
*Surgery (complete response) vs PDT (complete response); gMean +s.e.
colonies for mice with complete responses were similar to responses, the combination of PDT and surgery induced a
those shown in Table I but in this case there was no decreased number of metastatic lung colonies compared to
statistical significant difference between surgery and PDT either surgery alone (performed on either day 5 or day 6) or
treatment. No conclusion can be made for the 400Jcm 2 PhotofrinII and surgery.
PDT dose since only two mice had complete responses. Table IV documents the incidence of metastatic lung
Table III shows the incidence of metastatic lung colonies colonies in C57BL/6 mice when localized PDT preceeded
in LLC bearing mice when PDT was followed by surgery. LLC transplantation. PDT delivered 24h prior to LLC
For these experiments, 200Jcm-2 of PDT was used and this transplantation had no effect on subsequent induction of
dose of PDT by itself did not induce any complete responses. metastatic lung colonies. Light doses ranged from 100-
The combination of PDT on day 5 and surgery on day 6 400Jcm 2 and the left hind limb was used for PDT
resulted in 8 mice having a partial response and 11 mice exposure while the right hind limb was used for tumour cell
having a complete response. For mice with complete transplantation. Contralateral legs were used for this set of30 C.J. GOMER et a1l.
Table III Effect of photodynamic therapy followed by surgery on the incidence of lung
metastasis in C57BL/6 mice with Lewis lung carcinomaa.
Average number oflung colonies
Number of No Partial Complete
Treatment mice responseb responsec responsed P values'
Control 83 67.9 +8.5
Photofrin 11(10 mgkg-') 33 64.0+6.3
Surgery (day 5) 22 18.5 +6.6
Surgery (day 5) 10 13.9+ 6.1
Surgery (day 6) 31 29.9+4.0
Photofrin II (day 4) plus
Surgery (day 6) 11 43.5 +9.7
PDT (day 5)f 7 34.1 + 11.4
PDT (day 5) plus
Surgery (day 6) 8 42.6 + 12.4
PDT (day 5) plus
Surgery (day 6) 11 6.6+3.6 >0.1*
<0.Olt
aLungs examined 21 days following tumour transplantation; bNo response - tumour
did not respond to treatment; cPartial response - local tumour regrowth prior to sacrifice;
dComplete response - no local tumour present at time of sacrifice; eTwo tailed Student t
test: *Surgery (day 5) vs PDT (day 5)+surgery (day 6), tSurgery (day 6) vs PDT (day 5)
+surgery (day 6); fPhotodynamic therapy (PDT) consisted of a 10mgkg-' dose of
Photofrin II followed 24h later by 200Jcm2 delivered at 150mWcm-2.
Table IV Incidence of lung metastasis in C57BL/6 mice when
photodynamic therapy preceeds Lewis lung carcinoma
transplantationa.b.
Number of Average number of
Treatment mice lung colonies P valuesc
Control 15 72.1 + 9.6d
Photofrin II 11 86.3 + 8.2 >0.1
PDT, I00Jcm-2 10 95.3+15.3 >0.1
PDT, 200Jcm-2 12 76.6+ 13.3 >0.1
PDT, 300Jcm-2 10 72.3+ 7.5 >0.1
PDT, 400Jcm-2 9 73.0+ 8.5 >0.1
aLungs examined 21 days following tumour transplantation;
bPhotofrn II (10mgkg-1) administered 48 h prior to trans-
plantation, PDT was delivered to 1 cm diameter area of the left
hind leg 24 h prior to tumour transplantation to the right hind
leg; 'Two tailed Student t test; dMean + s.e.
experiments in order to avoid possible artifacts related to that localized PDT does not enhance the dissemination of
tumour bed effects. tumour metastasis in the LLC tumour model. Mice treated
with PDT had significantly lower numbers of metastatic lung
colonies than comparable control groups. In fact, the
Discussion number of metastatic lung colonies observed following a
range of PDT doses which produced either partial or
There is no evidence from the limited number of clinical complete local tumour responses were either comparable to
PDT studies that this modality induces an increase in the or lower than that observed in mice treated by local surgical
metastatic rate or potential of malignant tumours. However, excision of the tumour. Treatment of tumour-bearing mice
there are similarities between PDT and hyperthermia in that with Photofrin II alone or light treatment alone, as well as
both procedures can induce significant damage to the PDT delivered to mice prior to LLC transplantation had no
tumour vasculature (Star et al., 1986; Berenbaum et al., effect on local tumour growth or subsequent lung metastasis.
1986; Hahn, 1982; Eddy, 1980). Direct trauma or damage to While extrapolation of in vivo data to possible clinical effects
a primary tumour may cause an increase in the number of is not possible, it would appear that PDT will not induce
tumour cells released into the circulation (Hill & Denekamp, significant side-effects related to metastatic spread of
1982), although this process may not always induce malignant tumours.
metastasis (Salisbury, 1975). In the case of hyperthermia, Mice with subcutaneously growing LLC develop
there still remains a controversy related to its role in the pulmonary metastases in a reproducible manner. In addition,
spread of metastasis (Hahn, 1982; Hill & Denekamp, 1982; the LLC tumour has not been observed to regress
Oda et al., 1985; Yerulshalmi, 1970; Hahn et at., 1979). The spontaneously (Yerushalmi, 1976), and has been reported to
majority of evidence suggests that localized hyperthermia be responsive to local PDT treatment (Cowled & Forbes,
does not effect metastatic spread, whereas total body 1985). The LLC tumour model has also been used to study
hyperthermia appears to increase the incidence of metastatic metastatic spread following local and whole body hyper-
spread. Stress induced by surgery is also suggested to play a thermia (Oda et at., 1986; Yerushalmi, 1976), surgery
role in a hyper-metastatic state in the in vivo LLC tumour (Pollack et at., 1984), prostaglandins (Young & Knies, 1984),
model (Pollak et at., 1984). The results of our study indicate cytotoxic drugs (Stahl et at., 1985) and anaesthetics (ShapiroLOCALIZED PORPHYRIN PHOTODYNAMIC THERAPY 31
et al., 1981). Our study was designed to utilize the LLC
tumour model to specifically examine the role of localized
PDT in the induction of metastases. It is of interest to note
that relatively high doses of PDT were required for local
tumour control during the 2 week period between treatment
and sacrifice of animals. Partial responses (or tumour
recurrences) developed in 13 out of 18 mice receiving a
10mgkg-I dose of Photofrin II and a 400Jcm-2 light dose
(Table 1). Eight out of 14 mice treated with PhotofrinII and
a 500 Jcm-2 dose of light also had recurrences within the 2
week period. The high degree of resistance of the LLC to
PDT is probably not due to tumour tissue hypoxia since the
LLC has been shown to be sensitive to ionizing radiation
(Shipley et al., 1975; Lvovsky et al., 1985). Skin pig-
mentation and light attenuation may play a role in the in
vivo PDT resistance observed in the LLC.
Recent studies have shown that PDT can induce systemic
immunosuppression related to inhibition of contact hyper-
sensitivity of dinitrofluorobenzene (Elmets & Bowen, 1986).
The immunosuppression induced by PDT may be mediated
by activation of the complement system (Lim et al., 1984;
Lim et al., 1985). We have observed a transient decrease in
splenic natural killer (NK) cell activity following localized
PDT in mice (Gomer et al., 1986). Therefore, while PDT
does not enhance metastatic spread in an experimental
animal model, it does appear as though this modality can
induce immunosuppression related to both T cells
(documented in hypersensitivity reactions) and NK cells.
However, localized PDT delivered to mice prior to LLC
transplantation did not effect either the rate or quantity of
subsequent metastatic lung colonies.
In summary, the documented side-effects related to PDT
continue to be restricted to transient skin photosensitization.
The current study indicates that local PDT does not enhance
the spread of tumour metastasis. Additional investigations
related to this area would appear warranted in view of both
the vascular and immunological action of PDT. However,
since PDT has been shown to be an effective tumoricidal
procedure, the results of this study would support the
continued clinical examination of PDT in the treatment of
both advanced as well as early stage malignancies.
We thank Barbara Paul for assistance in the preparation of this
manuscript. This investigation was performed in conjunction with
the Clayton Foundation for Research and was supported in part by
USPHS Grant CA-31230 awarded by NCI, NHHS.
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